Insulin-like growth factor binding protein proteolysis

Trends in Endocrinology and Metabolism

Volumn 14, Issue 4, 2003, Pages 176-181

  Bunn, R Clay ^a   Fowlkes, John L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C;

BINDING AFFINITY; BODY FLUID; CELL DIFFERENTIATION; CELL SURFACE; CELL SURVIVAL; ENZYME INACTIVATION; HUMAN; MITOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0038070060     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(03)00049-3     Document Type: Review

References (63)

1. Baxter, R.C. (2000) Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am. J. Physiol. 278, E967-E976
2. Rajaram, S. et al. (1997) Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr. Rev. 18, 801-831
3. Jones, J.I. and Clemmons, D.R. (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16, 3-34
4. Shimasaki, S. and Ling, N. (1991) Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog. Growth Factor Res. 3, 243-266
5. Rechler, M.M. (1993) Insulin-like growth factor binding proteins. Vitam. Horm. 47, 1-114
6. Hwa, V. et al. (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr. Rev. 20, 761-787
7. Busby, W.H. Jr et al. (2000) The complement component Cls is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium. J. Biol. Chem. 275, 37638-37644
8. Sim, R.B. and Laich, A. (2000) Serine proteases of the complement system. Biochem. Soc. Trans. 28, 545-550
9. Fowlkes, J.L. et al. (1994) Matrix metalloproteinases degrade insulinlike growth factor-binding protein-3 in dermal fibroblast cultures. J. Biol. Chem. 269, 25742-25746
10. Fowlkes, J.L. (1994) Degradation of insulin-like growth factor (IGF)binding protein-3 (IGFBP-3) by a metal-dependent protease produced by human fibroblasts: effects of IGFs on protease activity. Endocr. J. 2, 63-68
11. Martin, D.C. et al. (1999) Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1. J. Cell Biol. 146, 881-892
12. Thrailkill, K.M. et al. (1995) Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 136, 3527-3533
13. Nam, T.J. et al. (1996) Characterization and determination of the relative abundance of two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts. Endocrinology 137, 5530-5536
14. Rajah, R. et al. (1995) Insulin-like growth factor binding protein (IGFBP) proteases: functional regulators of cell growth. Prog. Growth Factor Res. 6, 273-284
15. Rajah, R. et al. (1996) 7S nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology 137, 2676-2682
16. Cohen, P. et al. (1995) Leukotriene D4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis. Am. J. Physiol. 269, L151-L157
17. Shi, Z. et al. (2000) ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3. J. Biol. Chem. 275, 18574-18580
18. Loechel, F. et al. (2000) ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem. Biophys. Res. Commun. 278, 511-515
19. Irwin, J.C. et al. (2000) Human placental trophoblasts secrete a disintegrin metalloproteinase very similar to the insulin-like growth factor binding protein-3 protease in human pregnancy serum. Endocrinology 141, 666-674
20. Lawrence, J.B. et al. (1999) The insulin-like growth factor (IGF)dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc. Natl. Acad. Sci. U. S. A. 96, 3149-3153
21. Conover, C.A. et al. (1999) Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A. J. Clin. Endocrinol. Metab. 84, 4742-4745
22. Byun, D. et al. (2001) Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro. J. Clin. Endocrinol. Metab. 86, 847-854
23. Overgaard, M.T. et al. (2000) Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J. Biol. Chem. 275, 31128-31133
24. Chen, B.K. et al. (2002) Molecular regulation of the IGF-binding protein-4 protease system in human fibroblasts: identification of a novel inducible inhibitor. Endocrinology 143, 1199-1205
25. Overgaard, M.T. et al. (2001) Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. J. Biol. Chem. 276, 21849-21853
26. Conover, C.A. and DeLeon, D.D. (1994) Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D. J. Biol. Chem. 269, 7076-7080
27. Braulke, T. et al. (1995) Proteolysis of IGFBPs by cathepsin D in vitro and in cathepsin D-deficient mice. Prog. Growth Factor Res. 6, 265-271
28. Conover, C.A. et al. (1995) Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J. Clin. Endocrinol. Metab. 80, 987-993
29. Braulke, T. et al. (1999) Alteration in pancreatic immunoreactivity of insulin-like growth factor (IGF)-binding protein (IGFBP)-6 and in intracellular degradation of IGFBP-3 in fibroblasts of IGF-II receptor/IGF-II-deficient mice. Horm. Metab. Res. 31, 235-241
30. Zwad, O. et al. (2002) Decreased intracellular degradation of insulin-like growth factor binding protein-3 in cathepsin L-deficient fibroblasts. FEBS Lett. 510, 211-215
31. Clemmons, D.R. (1998) Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol. Cell. Endocrinol. 140, 19-24
32. Baxter, R.C. (2001) Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol. Pathol. 54, 145-148
33. Lalou, C. et al. (1996) A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137, 3206-3212
34. Lalou, C. et al. (1996) Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3. Horm. Res. 45, 156-159
35. Vorwerk, P. et al. (1998) Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine. J. Clin. Endocrinol. Metab. 83, 1392-1395
36. Yamanaka, Y. et al. (1997) Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J. Biol. Chem. 272, 30729-30734
37. Zadeh, S.M. and Binoux, M. (1997) The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action offibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Endocrinology 138, 3069-3072
38. Gill, Z.P. et al. (1997) Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J. Biol. Chem. 272, 25602-25607
39. Maile, L.A. et al. (1999) The role of cell surface attachment and proteolysis in the insulin-like growth factor (IGF)-independent effects of IGF-binding protein-3 on apoptosis in breast epithelial cells. Endocrinology 140, 4040-4045
40. Salahifar, H. et al. (2000) Characterization of an amino-terminal fragment of insulin-like growth factor binding protein-3 and its effects in MCF-7 breast cancer cells. Growth Horm. IGF Res. 10, 367-377
41. Bernard, L. et al. (2002) The amino-terminal region of insulin-like growth factor binding protein-3, (1-95)IGFBP-3, induces apoptosis of MCF-7 breast carcinoma cells. Biochem. Biophys. Res. Commun. 293, 55-60
42. Neumann, G.M. et al. (1998) Identification of O-glycosylation sites and partial characterization of carbohydrate structure and disulfide linkages of human insulin-like growth factor binding protein 6. Biochemistry 37, 6572-6585
43. Gibson, J.M. et al. (2001) Regulation of IGF bioavailability in pregnancy. Mol. Hum. Reprod. 7, 79-87
44. Coverley, J.A. et al. (2000) The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3. Endocrinology 141, 564-570
45. Fowlkes, J.L. et al. (1997) Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation. Endocrinology 138, 2280-2285
46. Campbell, P.G. and Andress, D.L. (1997) Plasmin degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): regulation by IGFBP-5-(201-218). Am. J. Physiol. 273, E996-1004
47. Durham, S.K. et al. (1999) The heparin binding domain of insulin-like growth factor binding protein (IGFBP)-3 increases susceptibility of IGFBP-3 to proteolysis. Horm. Metab. Res. 31, 216-225
48. Monget, P. et al. (2003) Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation. Biol. Reprod. 68, 77-86
49. Zhang, M. et al. (2002) Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy. J. Biol. Chem. 277, 21285-21290
50. Fowlkes, J. and Freemark, M. (1992) Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. Endocrinology 131, 2071-2076
51. Qin, X. et al. (2000) Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. Arch. Biochem. Biophys. 379, 209-216
52. Laursen, L.S. et al. (2001) Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett. 504, 36-40
53. Gockerman, A. and Clemmons, D.R. (1995) Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2. Circ. Res. 76, 514-521
54. Jones, J.I. et al. (1993) Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J. Cell Biol. 121, 679-687
55. Conover, C.A. (1991) Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3. Endocrinology 129, 3259-3268
56. Davenport, M.L. et al. (1992) Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. J. Clin. Endocrinol. Metab. 75, 590-595
57. Shinada, M. et al. (2000) Proteolysis of insulin-like growth factorbinding protein-3 is increased in urine from patients with diabetic nephropathy. J. Clin. Endocrinol. Metab. 85, 1163-1169
58. Muller, H.L. et al. (1994) Insulin-like growth factor binding protein-3 concentrations and insulin-like growth factor binding protein-3 protease activity in sera of patients with malignant solid tumors or leukemia. Pediatr. Res. 35, 720-724
59. Helle, S.I. et al. (2001) Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer. Br. J. Cancer 85, 74-77
60. Baciuchka, M. et al. (1998) Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) proteolysis in patients with colorectal cancer: possible association with the metastatic potential of the tumor. Int. J. Cancer 79, 460-467
61. Bayes-Genis, A. et al. (2001) Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler. Thromb. Vasc. Biol. 21, 335-341
62. Bayes-Genis, A. et al. (2001) Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N. Engl. J. Med. 345, 1022-1029
63. Clemmons, D.R. et al. (2002) Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis. Arthritis Rheum. 46, 694-703